David L. Cohn
- Infectious Diseases top 0.1%
- Epidemiology top 0.2%
- Surgery top 1%
- Pharmacology top 0.5%
- Virology top 1%
- Co-authors
- James L. MelsaTimothy R. SterlingMario RaviǵlioneFlavia BustreoRandall RevesFred M. GordinWilliam J. BurmanPhilip LoBue
- Topics
- Tuberculosis Research and Epidemiology (52 papers)Pneumocystis jirovecii pneumonia detection and treatment (29 papers)Mycobacterium research and diagnosis (20 papers)
- Partner nations
- United StatesUnited KingdomUganda
In The Last Decade
David L. Cohn
149 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 200
- Infectious Diseases 5.0k
- Epidemiology 4.6k
- Surgery 2.1k
- Pharmacology 536
- Virology 512
Countries citing papers authored by David L. Cohn
This map shows the geographic impact of David L. Cohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Cohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Cohn more than expected).
Fields of papers citing papers by David L. Cohn
This network shows the impact of papers produced by David L. Cohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Cohn. The network helps show where David L. Cohn may publish in the future.
Co-authorship network of co-authors of David L. Cohn
This figure shows the co-authorship network connecting the top 25 collaborators of David L. Cohn. A scholar is included among the top collaborators of David L. Cohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Cohn. David L. Cohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Business Artifacts: A Data-centric Approach to Modeling Business Operations and Processes | 167 |
| 2 | 4 | |
| 3 | 10 | |
| 4 | An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapybreakdown → | 814 |
| 5 | Autonomic Computing | 0 |
| 6 | 62 | |
| 7 | A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients | 1 |
| 8 | A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: Excess mortality associated with high-dose clarithromycin | 1 |
| 9 | 10 | |
| 10 | 25 | |
| 11 | Adaptive software | 11 |
| 12 | Protected shared libraries: a new approach to modularity and sharing | 12 |
| 13 | 57 | |
| 14 | 5 | |
| 15 | 55 | |
| 16 | 2 | |
| 17 | Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. | 43 |
| 18 | 21 | |
| 19 | 3 | |
| 20 | Bounds on the performance of a class of digital communication systems | 1 |
About David L. Cohn
David L. Cohn is a scholar working on Infectious Diseases, Virology and Epidemiology, having authored 157 papers that have together received 8.6k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (52 papers), Pneumocystis jirovecii pneumonia detection and treatment (29 papers) and Mycobacterium research and diagnosis (20 papers). The work is most often cited by research in Infectious Diseases (5.0k citations), Epidemiology (4.6k citations) and Virology (512 citations). David L. Cohn has collaborated with scholars based in United States, United Kingdom and Uganda. Frequent co-authors include James L. Melsa, Timothy R. Sterling, Mario Raviǵlione, Flavia Bustreo, Randall Reves, Fred M. Gordin, William J. Burman, Philip LoBue, Richard O’Brien and Richard Hull. Their work appears in journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.